AnalystsKevin DegeeterKevin Degeeter's Stock Forecasts
AnalystsKevin Degeeter
Analyst Ranking
Top 3%
#99 out of 4792 analysts
Average Return
+76.68%
Win Rate
29%9 out of 31
Risk vs Reward
Poor
Good
Kevin Degeeter's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Bionano Genomics IncBNGO | +2,385.15% | $3.03 | $75.30 | 2020-04-08 - 2021-04-08 | Buy |
Gyre Therapeutics IncGYRE | +473.83% | $64.20 | $368.40 | 2017-06-06 - 2018-06-06 | Strong Buy |
Orchard Therapeutics PLCORTX | +234.00% | $5.00 | $16.70 | 2023-06-13 - 2024-01-23 | Buy |
Orchard Therapeutics PLCORTX | +230.04% | $5.06 | $16.70 | 2023-08-09 - 2024-01-23 | Buy |
Ablynx NvABLX | +129.87% | $23.00 | $52.87 | 2017-11-20 - 2018-06-12 | Strong Buy |
Kevin Degeeter Analyst Color
Get additional color on Kevin Degeeter's coverage of popular stocks
Kevin Degeeter's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Orchard Therapeutics PLCORTX | 3 | Buy | $34.00 | N/A | Reiterates | a year ago |
An2 Therapeutics IncANTX | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 3 years ago |
Oric Pharmaceuticals IncORIC | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Novocure LtdNVCR | 1 | Buy | $98.00 | N/A | Upgrades | 3 years ago |
Fulgent Genetics IncFLGT | 2 | Buy | $125.00 | N/A | Maintains | 3 years ago |
Sera Prognostics IncSERA | 1 | Buy | $19.00 | N/A | Initiates Coverage On | 3 years ago |
Spero Therapeutics IncSPRO | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Portage Biotech IncPRTG | 1 | Buy | $600.00 | N/A | Initiates Coverage On | 3 years ago |
Palo Alto Networks IncPANW | 1 | Buy | $79.17 | N/A | Maintains | 3 years ago |
Exact Sciences CorpEXAS | 1 | Buy | $155.00 | N/A | Maintains | 3 years ago |
Sensei Biotherapeutics IncSNSE | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Rezolute IncRZLT | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 4 years ago |
Humanigen IncHGENQ | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 4 years ago |
Personalis IncPSNL | 2 | Buy | $28.00 | N/A | Upgrades | 4 years ago |
Cyclacel Pharmaceuticals IncCYCC | 1 | Buy | $255.00 | N/A | Initiates Coverage On | 4 years ago |
Invitae CorpNVTAQ | 2 | Buy | $48.00 | N/A | Upgrades | 4 years ago |
Evaxion Biotech AEVAX | 1 | Buy | $1,800.00 | N/A | Initiates Coverage On | 4 years ago |
9 Meters Biopharma IncNMTRQ | 1 | Buy | $120.00 | N/A | Initiates Coverage On | 4 years ago |
Dermtech IncDMTKQ | 1 | Buy | $53.00 | N/A | Initiates Coverage On | 4 years ago |
Taysha Gene Therapies IncTSHA | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Cellectar Biosciences IncCLRB | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 5 years ago |
Notable Labs LtdNTBLQ | 1 | Buy | $3.00 | N/A | Maintains | 5 years ago |
Bionano Genomics IncBNGO | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 5 years ago |
Interpace Biosciences IncIDXG | 1 | Buy | $17.00 | N/A | Maintains | 5 years ago |
Athenex IncATNXQ | 1 | Buy | $400.00 | N/A | Initiates Coverage On | 6 years ago |
Genomic Health IncGHDX | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Prometheus Biosciences IncRXDX | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Ablynx NvABLX | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 7 years ago |
Combimatrix CorpCBMX | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Molecular Templates IncMTEM | 1 | Strong Buy | $150.00 | N/A | Initiates Coverage On | 7 years ago |
Gyre Therapeutics IncGYRE | 1 | Strong Buy | $11.00 | N/A | Initiates Coverage On | 8 years ago |
Cidara Therapeutics IncCDTX | 1 | Strong Buy | $225.00 | N/A | Initiates Coverage On | 8 years ago |
Myriad Genetics IncMYGN | 1 | Hold | N/A | N/A | Upgrades | 8 years ago |
Codexis IncCDXS | 1 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.